Citius Pharmaceuticals (CTXR) Income After Tax (2010 - 2026)
Citius Pharmaceuticals (CTXR) posted Income After Tax of -$11.92 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$9.2 million a year earlier.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Income After Tax (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income After Tax at Citius Pharmaceuticals was -$58.17 million; for FY2025 (ended Sep 30, 2025), it came in at -$39.74 million.
- In prior fiscal years, Citius Pharmaceuticals' Income After Tax was -$41.24 million in FY2024, -$32.54 million in FY2023, -$33.64 million in FY2022 and -$23.05 million in FY2021.
- Quarterly Income After Tax has run from a low of -$28.11 million in fiscal Q2 2026 to a high of -$3.59 million in fiscal Q1 2023 over five years.
- According to Business Quant data, Income After Tax for the three prior fiscal quarters was -$28.11 million (Q2 2026), -$9.39 million (Q1 2026) and -$8.74 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Citius Pharmaceuticals | 13.45 Mn | -10.82 Mn | 1.00 Mn | -11.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.92 Mn |
| Mar 31, 2026 | -28.11 Mn |
| Dec 31, 2025 | -9.39 Mn |
| Jun 30, 2025 | -9.20 Mn |
| Mar 31, 2025 | -11.51 Mn |
| Dec 31, 2024 | -10.28 Mn |
| Jun 30, 2024 | -10.57 Mn |
| Mar 31, 2024 | -10.79 Mn |
| Dec 31, 2023 | -9.23 Mn |
| Sep 30, 2023 | -9.94 Mn |
| Jun 30, 2023 | -8.48 Mn |
| Mar 31, 2023 | -10.53 Mn |
| Dec 31, 2022 | -3.59 Mn |
| Sep 30, 2022 | -7.41 Mn |
| Jun 30, 2022 | -8.86 Mn |
| Mar 31, 2022 | -7.56 Mn |
| Dec 31, 2021 | -9.23 Mn |
| Sep 30, 2021 | -5.13 Mn |
| Jun 30, 2021 | -5.88 Mn |
| Mar 31, 2021 | -4.12 Mn |
API Access
Citius Pharmaceuticals Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();